Premium
O4‐01‐06: A randomized, double‐blind placebo‐controlled trial of simvastatin on CSF, MRI, and cognitive biomarkers in middle‐aged adults at risk for Alzheimer's disease: The ESPRIT Study
Author(s) -
Carlsson Cynthia M.,
Gleason Carey E.,
Johnson Sterling C.,
Xu Guofan,
Huang Yin,
Barnet Jodi,
Fain Sean,
Blazel Hanna,
Zetterberg Henrik,
Blennow Kaj,
Hermann Bruce P.,
Dowling N. Maritza,
Newman George C.,
Puglielli Luigi,
Atwood Craig S.,
Rowley Howard,
Sager Mark,
Asthana Sanjay
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.470
Subject(s) - asymptomatic , medicine , simvastatin , placebo , cognitive decline , randomized controlled trial , disease , pathology , dementia , alternative medicine